Kampo Medicine Treatment for Advanced Pancreatic Cancer: A Case Series
- PMID: 34458306
- PMCID: PMC8387656
- DOI: 10.3389/fnut.2021.702812
Kampo Medicine Treatment for Advanced Pancreatic Cancer: A Case Series
Abstract
Aims: The present report aims to investigate the use of Kampo medicine for advanced pancreatic cancer patients in order to prolong survival. Methods: We retrospectively reviewed medical records of patients with pancreatic cancer who presented to our Shimizu Clinic from 2000 to 2020. Patients who survived at least twice as long as the initial prognostic estimate were selected and their treatment was reviewed. The Kampo formula and crude drugs were selected according to the Kampo diagnosis and treatment strategy, which included qi and blood supplementation; qi, blood and water smoothing; and inflammation (termed "heat") and cancer suppression. Results: Ten patients aged 45-80 years (six males and four females) with stage IV advanced cancer were selected. All patients received hozai, which is a tonic formula, of juzentaihoto (JTT) or hochuekkito (HET) decoction. Anti-cancer crude drugs were included in the decoctions of nine patients. At the first visit, the estimated life expectancy for all patients was no more than 1 year; however, treatment with Western and Kampo medicine led to a relatively long survival period of over 2 years. Three patients were still living at the time of this writing, more than 2, 6, and 14 years after treatment initiation. Conclusion: Our results suggest that Kampo medicine may be useful for disease control and supportive care for patients with advanced pancreatic cancer.
Keywords: Kampo medicine; integrative therapy; pancreatic cancer; prolong survival; quality of life.
Copyright © 2021 Shimizu, Takayama, Kikuchi, Arita, Ono, Ishizawa and Ishii.
Conflict of interest statement
ST, AK, and TI belong to the Department of Kampo and Integrative Medicine at the Tohoku University School of Medicine. The department received a grant from Tsumura, a Japanese manufacturer of Kampo medicine; however, this grant was used as per Tohoku University rules. Potential conflicts of interest were addressed by the Tohoku University Benefit Reciprocity Committee and managed appropriately. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Integrative therapy for advanced pancreatic cancer using Kampo and western medicine: A case report.Explore (NY). 2021 May-Jun;17(3):255-258. doi: 10.1016/j.explore.2020.07.003. Epub 2020 Jul 16. Explore (NY). 2021. PMID: 32736951
-
Comparative study of the effects of the three kinds of Kampo-hozai: Ninjinyoeito, Hochuekkito, and Juzentaihoto on anxious and low sociability behavior using NPY-knockout zebrafish.Front Pharmacol. 2023 May 30;14:1168229. doi: 10.3389/fphar.2023.1168229. eCollection 2023. Front Pharmacol. 2023. PMID: 37324500 Free PMC article.
-
[Kampo Therapy for Patients with Cancer--The Role of Kampo Medicine in Team Therapy].Gan To Kagaku Ryoho. 2015 Dec;42(13):2414-7. Gan To Kagaku Ryoho. 2015. PMID: 26809298 Japanese.
-
Phytotherapy for Cachexia: Where Do We Stand?Front Pharmacol. 2020 Jul 8;11:917. doi: 10.3389/fphar.2020.00917. eCollection 2020. Front Pharmacol. 2020. PMID: 32733236 Free PMC article. Review.
-
Kampo (Traditional Japanese Herbal) Formulae for Treatment of Stomatitis and Oral Mucositis.Medicines (Basel). 2018 Dec 10;5(4):130. doi: 10.3390/medicines5040130. Medicines (Basel). 2018. PMID: 30544681 Free PMC article. Review.
Cited by
-
Current status of Complementary and Alternative Medicine Interventions in the Management of Pancreatic Cancer - An Overview.Curr Treat Options Oncol. 2023 Dec;24(12):1852-1869. doi: 10.1007/s11864-023-01146-4. Epub 2023 Dec 11. Curr Treat Options Oncol. 2023. PMID: 38079061 Free PMC article. Review.
-
How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?Pharmaceuticals (Basel). 2022 Jul 14;15(7):868. doi: 10.3390/ph15070868. Pharmaceuticals (Basel). 2022. PMID: 35890166 Free PMC article. Review.
-
Case Report: Prolonged Anorexia With Nausea Caused by Immune Checkpoint Inhibitors for Malignant Melanoma Treated Using Kampo Medicines Bukuryoingohangekobokuto and Ninjin'yoeito.Front Pharmacol. 2022 Apr 12;13:870823. doi: 10.3389/fphar.2022.870823. eCollection 2022. Front Pharmacol. 2022. PMID: 35496285 Free PMC article.
-
Prolonged survival by combination treatment with a standardized herbal extract from Japanese Kampo-medicine (Juzentaihoto) and gemcitabine in an orthotopic transplantation pancreatic cancer model.Front Oncol. 2024 Dec 11;14:1454291. doi: 10.3389/fonc.2024.1454291. eCollection 2024. Front Oncol. 2024. PMID: 39723364 Free PMC article.
-
Cancer and Traditional Medicine: An Integrative Approach.Pharmaceuticals (Basel). 2025 Apr 28;18(5):644. doi: 10.3390/ph18050644. Pharmaceuticals (Basel). 2025. PMID: 40430464 Free PMC article. Review.
References
-
- Ganjoho.jp [statistics internet page] . Total Cancer Registration Survival Rate in Hospitals such as Cancer Treatment Cooperation Base Hospitals. (2019). Available online at: https://ganjoho.jp/reg_stat/statistics/brochure/hosp_c_reg_surv.html (accessed Febraury 12, 2021).
-
- Iwase S, Yamaguchi T, Miyaji T, Terawaki S, Inui A, Uezono Y. The clinical use of Kampo medicines (traditional Japanese herbal treatments) for controlling cancer patients' symptoms in Japan: a national cross-sectional survey. BMC Complement Altern Med. (2012) 20:222. 10.1186/1472-6882-12-222 - DOI - PMC - PubMed
-
- Japanese Society for Palliative Medicine . Clinical Evidence for Complementary and Alternative Therapies in Cancer Patients. Tokyo: Kanehara & Co., Ltd. (2016). Available online at: https://www.jspm.ne.jp/guidelines/cam/2016/pdf/cam01.pdf
Publication types
LinkOut - more resources
Full Text Sources